Back
The proportion testing positive for SARS-COV-2 among the tested population in the U.S.: Benefits of the positive test ratio under scaled testing scenarios
Ng, G.; Wang, C.
2020-04-26
epidemiology
10.1101/2020.04.21.20074070
medRxiv
Show abstract
The ratios offer simple ways to account for variations in testing and reporting. Tracking the ratios in addition to cases offer a more precise view of the pandemic. Our observations underscore the need to scale mass testing with accurate and reliable tests, to implement testing systematically and report results consistently.
Matching journals
●Non-profit
◐University press
○Commercial
The top 4 journals account for 50% of the predicted probability mass.
1
PLOS ONE
●
5266 papers in training set
Top 10%
18.8%
Similar papers in this journal
- Identifying Optimal COVID-19 Testing Strategies for Schools and Businesses: Balancing Testing Frequency, Individual Test Technology, and Cost 93%
- Threshold analyses on rates of testing, transmission, and contact for COVID-19 control in a university setting 93%
- Estimation of the fraction of COVID-19 infected people in U.S. states and countries worldwide 93%
2
Epidemics
○
116 papers in training set
Top 0.1%
18.8%
Similar papers in this journal
3
American Journal of Epidemiology
◐
67 papers in training set
Top 0.1%
7.4%
Similar papers in this journal
4
Clinical Infectious Diseases
◐
235 papers in training set
Top 0.4%
6.3%
Similar papers in this journal
- Modeling reductions in SARS-CoV-2 transmission and hospital burden achieved by prioritizing testing using a clinical prediction rule 91%
- Modeling effectiveness of testing strategies to prevent COVID-19 in nursing homes —United States, 2020 90%
- Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022 90%
50% of probability mass above
5
Scientific Reports
○
3612 papers in training set
Top 14%
5.6%
Similar papers in this journal
- Predictive values, uncertainty, and interpretation of serology tests for the novel coronavirus 93%
- Benchmarking the CoVID-19 pandemic across countries and states in the U.S.A. under heterogeneous testing 93%
- A Syndromic Surveillance Tool to Detect Anomalous Clusters of COVID-19 Symptoms in the United States 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.